Louise A. Burton

Dundee, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial.

Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial.

Journal: PloS one

Published: May 14, 2024

ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial.

ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial.

Journal: PloS one

Published: June 06, 2023

Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trial.

Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trial.

Journal: PloS one

Published: May 30, 2023

Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial.

Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial.

Journal: Journal of cachexia, sarcopenia and muscle

Published: July 16, 2021

Acceptability and feasibility of magnetic femoral nerve stimulation in older, functionally impaired patients.

Acceptability and feasibility of magnetic femoral nerve stimulation in older, functionally impaired patients.

Journal: BMC research notes

Published: March 24, 2018

Hospital-acquired pneumonia incidence and diagnosis in older patients.

Hospital-acquired pneumonia incidence and diagnosis in older patients.

Journal: Age and ageing

Published: July 02, 2015

Effect of spironolactone on physical performance in older people with self-reported physical disability.

Effect of spironolactone on physical performance in older people with self-reported physical disability.

Journal: The American journal of medicine

Published: February 20, 2012

Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people?

Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people?

Journal: Clinical endocrinology

Published: June 25, 2011

Showing 1-8 of 8

Last Updated: 09/26/2026